AU2002324395A1 - Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents - Google Patents

Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents

Info

Publication number
AU2002324395A1
AU2002324395A1 AU2002324395A AU2002324395A AU2002324395A1 AU 2002324395 A1 AU2002324395 A1 AU 2002324395A1 AU 2002324395 A AU2002324395 A AU 2002324395A AU 2002324395 A AU2002324395 A AU 2002324395A AU 2002324395 A1 AU2002324395 A1 AU 2002324395A1
Authority
AU
Australia
Prior art keywords
arylpiperidines
arylpiperazines
inhibiting agents
metalloproteinase inhibiting
metalloproteinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002324395A
Inventor
Raymond Finlay
Howard Tucker
David Waterson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2002324395A1 publication Critical patent/AU2002324395A1/en
Abandoned legal-status Critical Current

Links

AU2002324395A 2001-08-09 2002-08-08 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents Abandoned AU2002324395A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0119474.5 2001-08-09

Publications (1)

Publication Number Publication Date
AU2002324395A1 true AU2002324395A1 (en) 2003-02-24

Family

ID=

Similar Documents

Publication Publication Date Title
HUP0400202A3 (en) Imidazolidindion derivatives having metalloproteinase inhibitor effect, their use and pharmaceutical compositions containing them
HUP0300855A3 (en) Peptidmomimetic protease inhibitors, pharmaceutical compositions and their use
AU2001265008A1 (en) Caspase inhibitors and uses thereof
TWI318207B (en) Carbamate caspase inhibitors and uses thereof
HK1068555A1 (en) New formulations and use thereof
AU2001249969A1 (en) Inha inhibitors and their use as antibacterials
AU2002326432A1 (en) Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
IL154553A0 (en) Urocortin-iii and uses thereof
GB0121387D0 (en) Modified hydrolases
IL150882A0 (en) Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
PL363544A1 (en) Piperazino-derivatives and their use as pde4 inhibitor
EP1511753A4 (en) Antimicrobial agents and uses thereof
GB0126889D0 (en) Compounds and their uses
AU2001241498A1 (en) Matrix metalloproteinase inhibitors and uses thereof
AU2003258942A1 (en) Imidazolidinedione-derivatives and their use as metalloproteinase inhibitors
AU2001232113A1 (en) Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
AU1039801A (en) Compounds and their use as cysteine protease inhibitors
AU4432001A (en) Trityl-type compounds and their use
AU2002324395A1 (en) Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
AU2002321974A1 (en) Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
AU2002321973A1 (en) Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
EP1367123A4 (en) Neurotonin and use thereof
AU2001234180A1 (en) Benzamide derivative and use thereof
AU2001274683A1 (en) Contrast agents
SI1453783T1 (en) Substituted aryl-cycloalkanes, and use thereof as anticancer agents